Yuma Shimizu, Ippei Takeuchi, Masakazu Hatano, Manako Hanya, Kiyoshi Fujita, Nakao Iwata, Hiroyuki Kamei. Development of a cognitive function assessment tool based on psychomotor function tests in patients with schizophrenia. Schizophrenia research. Cognition. 2025. 42. 100390-100390
Taro Kishi, Kenji Sakuma, Masakazu Hatano, Shun Hamanaka, Yasufumi Nishii, Nakao Iwata. Relapse rates in stable obsessive-compulsive disorder after antidepressant discontinuation versus maintenance: A systematic review and meta-analysis. Psychological medicine. 2025. 55. e252
Taro Kishi, Toshikazu Ikuta, Leslie Citrome, Kenji Sakuma, Masakazu Hatano, Shun Hamanaka, Yasufumi Nishii, Nakao Iwata. Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis. Translational psychiatry. 2025. 15. 1. 211-211
Takenao Koseki, Hirofumi Hamano, Masakazu Hatano, Takao Tobe, Ryo Ieda, Tsuyoshi Nakai, Yoshito Zamami, Shigeki Yamada. Fractures Associated with Immune Checkpoint Inhibitors: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database. Pharmaceuticals. 2025. 18. 3. 333-333
Taro Kishi, Leslie Citrome, Kenji Sakuma, Shun Hamanaka, Yasufumi Nishii, Masakazu Hatano, Osamu Furukawa, Youichi Saito, Nakao Iwata. Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes. Pharmacopsychiatry. 2025
2022/02 - Asian Conference on Clinical Pharmacy Best Poster Presenter Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study